Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,372,083
-$130,671 QoQ
Shares Held
8,755
-11.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#529
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Douglass Winthrop Advisors, LLC holds $62,081,020 across 7 Drug Manufacturers - General names. NVS ranks #5 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
22,774 | $27,315,821 | |
| 2 | JNJ |
Johnson & Johnson
|
104,526 | $26,546,468 | |
| 3 | AMGN |
Amgen Inc
|
8,961 | $3,244,957 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
27,548 | $1,587,315 | |
| 5 | NVS |
Novartis AG
This page
|
8,755 | $1,372,083 | |
| 6 | PFE |
Pfizer Inc
|
52,079 | $1,254,062 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
6,018 | $760,314 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,372,083 | 8,755 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,502,754 | 9,838 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,356,365 | 9,838 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,235,977 | 9,638 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $820,568 | 6,781 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $755,945 | 6,781 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $666,670 | 6,851 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $806,060 | 7,008 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $746,071 | 7,008 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $691,426 | 7,148 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $700,529 | 6,938 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $706,704 | 6,938 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $700,113 | 6,938 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $638,296 | 6,938 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $629,415 | 6,938 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $588,165 | 7,738 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $835,832 | 9,888 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $835,029 | 9,516 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $832,364 | 9,516 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,170,108 | 14,308 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,337,395 | 14,658 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $1,295,705 | 15,158 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,647,520 | 17,447 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $1,571,541 | 18,072 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $896,981 | 10,270 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $1,044,641 | 12,670 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||